Global Meningococcal Vaccine Market Insights, Forecast to 2026
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Meningococcal Vaccine 3900 industry.
Based on our recent survey, we have several different scenarios about the Meningococcal Vaccine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 239 million in 2019. The market size of Meningococcal Vaccine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Vaccine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Meningococcal Vaccine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Meningococcal Vaccine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Meningococcal Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Vaccine market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Meningococcal Vaccine 3900 industry.
Based on our recent survey, we have several different scenarios about the Meningococcal Vaccine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 239 million in 2019. The market size of Meningococcal Vaccine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Vaccine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Meningococcal Vaccine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Meningococcal Vaccine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Meningococcal Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Vaccine market.
The following manufacturers are covered in this report:
- Novartis
- GSK
- Merck
- CSL
- Baxter
- JN International Medical Corporation
- Serum Institute of India
- Bio-Med
- China National Biotec Group
- Hualan Bio
- Walvax
- Zhifei
- Quadrivalent
- Bivalent
- Others
- Pneumonia
- Meningitis
- Bacteremia
- Others (Arthritis, Conjunctivitis, Urethritis)
1 STUDY COVERAGE
1.1 Meningococcal Vaccine Product Introduction
1.2 Market Segments
1.3 Key Meningococcal Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
1.4.2 Quadrivalent
1.4.3 Bivalent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Coronavirus Disease 2019 (Covid-19): Meningococcal Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Meningococcal Vaccine Industry
1.6.1.1 Meningococcal Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Meningococcal Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Meningococcal Vaccine Market Size Estimates and Forecasts
2.1.1 Global Meningococcal Vaccine Revenue 2015-2026
2.1.2 Global Meningococcal Vaccine Sales 2015-2026
2.2 Meningococcal Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Meningococcal Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meningococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MENINGOCOCCAL VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Meningococcal Vaccine Sales by Manufacturers
3.1.1 Meningococcal Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Meningococcal Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Meningococcal Vaccine Revenue by Manufacturers
3.2.1 Meningococcal Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Meningococcal Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2019
3.2.5 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meningococcal Vaccine Price by Manufacturers
3.4 Meningococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Meningococcal Vaccine Market Size by Type (2015-2020)
4.1.1 Global Meningococcal Vaccine Sales by Type (2015-2020)
4.1.2 Global Meningococcal Vaccine Revenue by Type (2015-2020)
4.1.3 Meningococcal Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningococcal Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Meningococcal Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningococcal Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Meningococcal Vaccine Market Size by Application (2015-2020)
5.1.1 Global Meningococcal Vaccine Sales by Application (2015-2020)
5.1.2 Global Meningococcal Vaccine Revenue by Application (2015-2020)
5.1.3 Meningococcal Vaccine Price by Application (2015-2020)
5.2 Meningococcal Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Meningococcal Vaccine by Country
6.1.1 North America Meningococcal Vaccine Sales by Country
6.1.2 North America Meningococcal Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meningococcal Vaccine Market Facts & Figures by Type
6.3 North America Meningococcal Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Meningococcal Vaccine by Country
7.1.1 Europe Meningococcal Vaccine Sales by Country
7.1.2 Europe Meningococcal Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Vaccine Market Facts & Figures by Type
7.3 Europe Meningococcal Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Meningococcal Vaccine by Region
8.1.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Meningococcal Vaccine by Country
9.1.1 Latin America Meningococcal Vaccine Sales by Country
9.1.2 Latin America Meningococcal Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meningococcal Vaccine Market Facts & Figures by Type
9.3 Central & South America Meningococcal Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Meningococcal Vaccine by Country
10.1.1 Middle East and Africa Meningococcal Vaccine Sales by Country
10.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Meningococcal Vaccine Products Offered
11.1.5 Novartis Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Meningococcal Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Meningococcal Vaccine Products Offered
11.3.5 Merck Recent Development
11.4 CSL
11.4.1 CSL Corporation Information
11.4.2 CSL Description, Business Overview and Total Revenue
11.4.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CSL Meningococcal Vaccine Products Offered
11.4.5 CSL Recent Development
11.5 Baxter
11.5.1 Baxter Corporation Information
11.5.2 Baxter Description, Business Overview and Total Revenue
11.5.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Baxter Meningococcal Vaccine Products Offered
11.5.5 Baxter Recent Development
11.6 JN International Medical Corporation
11.6.1 JN International Medical Corporation Corporation Information
11.6.2 JN International Medical Corporation Description, Business Overview and Total Revenue
11.6.3 JN International Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
11.6.5 JN International Medical Corporation Recent Development
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Description, Business Overview and Total Revenue
11.7.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
11.7.5 Serum Institute of India Recent Development
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Description, Business Overview and Total Revenue
11.8.3 Bio-Med Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bio-Med Meningococcal Vaccine Products Offered
11.8.5 Bio-Med Recent Development
11.9 China National Biotec Group
11.9.1 China National Biotec Group Corporation Information
11.9.2 China National Biotec Group Description, Business Overview and Total Revenue
11.9.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
11.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
11.9.5 China National Biotec Group Recent Development
11.10 Hualan Bio
11.10.1 Hualan Bio Corporation Information
11.10.2 Hualan Bio Description, Business Overview and Total Revenue
11.10.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hualan Bio Meningococcal Vaccine Products Offered
11.10.5 Hualan Bio Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Meningococcal Vaccine Products Offered
11.1.5 Novartis Recent Development
11.12 Zhifei
11.12.1 Zhifei Corporation Information
11.12.2 Zhifei Description, Business Overview and Total Revenue
11.12.3 Zhifei Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Zhifei Products Offered
11.12.5 Zhifei Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Meningococcal Vaccine Market Estimates and Projections by Region
12.1.1 Global Meningococcal Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Meningococcal Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Meningococcal Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Meningococcal Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Meningococcal Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Meningococcal Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meningococcal Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meningococcal Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meningococcal Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Meningococcal Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Meningococcal Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meningococcal Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meningococcal Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningococcal Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Meningococcal Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Meningococcal Vaccine Product Introduction
1.2 Market Segments
1.3 Key Meningococcal Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
1.4.2 Quadrivalent
1.4.3 Bivalent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Coronavirus Disease 2019 (Covid-19): Meningococcal Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Meningococcal Vaccine Industry
1.6.1.1 Meningococcal Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Meningococcal Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Meningococcal Vaccine Market Size Estimates and Forecasts
2.1.1 Global Meningococcal Vaccine Revenue 2015-2026
2.1.2 Global Meningococcal Vaccine Sales 2015-2026
2.2 Meningococcal Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Meningococcal Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meningococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL MENINGOCOCCAL VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Meningococcal Vaccine Sales by Manufacturers
3.1.1 Meningococcal Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Meningococcal Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Meningococcal Vaccine Revenue by Manufacturers
3.2.1 Meningococcal Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Meningococcal Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2019
3.2.5 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meningococcal Vaccine Price by Manufacturers
3.4 Meningococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Meningococcal Vaccine Market Size by Type (2015-2020)
4.1.1 Global Meningococcal Vaccine Sales by Type (2015-2020)
4.1.2 Global Meningococcal Vaccine Revenue by Type (2015-2020)
4.1.3 Meningococcal Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningococcal Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Meningococcal Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningococcal Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Meningococcal Vaccine Market Size by Application (2015-2020)
5.1.1 Global Meningococcal Vaccine Sales by Application (2015-2020)
5.1.2 Global Meningococcal Vaccine Revenue by Application (2015-2020)
5.1.3 Meningococcal Vaccine Price by Application (2015-2020)
5.2 Meningococcal Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Meningococcal Vaccine by Country
6.1.1 North America Meningococcal Vaccine Sales by Country
6.1.2 North America Meningococcal Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meningococcal Vaccine Market Facts & Figures by Type
6.3 North America Meningococcal Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Meningococcal Vaccine by Country
7.1.1 Europe Meningococcal Vaccine Sales by Country
7.1.2 Europe Meningococcal Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Vaccine Market Facts & Figures by Type
7.3 Europe Meningococcal Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Meningococcal Vaccine by Region
8.1.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Meningococcal Vaccine by Country
9.1.1 Latin America Meningococcal Vaccine Sales by Country
9.1.2 Latin America Meningococcal Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meningococcal Vaccine Market Facts & Figures by Type
9.3 Central & South America Meningococcal Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Meningococcal Vaccine by Country
10.1.1 Middle East and Africa Meningococcal Vaccine Sales by Country
10.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Meningococcal Vaccine Products Offered
11.1.5 Novartis Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Meningococcal Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Meningococcal Vaccine Products Offered
11.3.5 Merck Recent Development
11.4 CSL
11.4.1 CSL Corporation Information
11.4.2 CSL Description, Business Overview and Total Revenue
11.4.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CSL Meningococcal Vaccine Products Offered
11.4.5 CSL Recent Development
11.5 Baxter
11.5.1 Baxter Corporation Information
11.5.2 Baxter Description, Business Overview and Total Revenue
11.5.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Baxter Meningococcal Vaccine Products Offered
11.5.5 Baxter Recent Development
11.6 JN International Medical Corporation
11.6.1 JN International Medical Corporation Corporation Information
11.6.2 JN International Medical Corporation Description, Business Overview and Total Revenue
11.6.3 JN International Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
11.6.5 JN International Medical Corporation Recent Development
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Description, Business Overview and Total Revenue
11.7.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
11.7.5 Serum Institute of India Recent Development
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Description, Business Overview and Total Revenue
11.8.3 Bio-Med Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bio-Med Meningococcal Vaccine Products Offered
11.8.5 Bio-Med Recent Development
11.9 China National Biotec Group
11.9.1 China National Biotec Group Corporation Information
11.9.2 China National Biotec Group Description, Business Overview and Total Revenue
11.9.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
11.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
11.9.5 China National Biotec Group Recent Development
11.10 Hualan Bio
11.10.1 Hualan Bio Corporation Information
11.10.2 Hualan Bio Description, Business Overview and Total Revenue
11.10.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hualan Bio Meningococcal Vaccine Products Offered
11.10.5 Hualan Bio Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Meningococcal Vaccine Products Offered
11.1.5 Novartis Recent Development
11.12 Zhifei
11.12.1 Zhifei Corporation Information
11.12.2 Zhifei Description, Business Overview and Total Revenue
11.12.3 Zhifei Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Zhifei Products Offered
11.12.5 Zhifei Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Meningococcal Vaccine Market Estimates and Projections by Region
12.1.1 Global Meningococcal Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Meningococcal Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Meningococcal Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Meningococcal Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Meningococcal Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Meningococcal Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meningococcal Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meningococcal Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meningococcal Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Meningococcal Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Meningococcal Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meningococcal Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meningococcal Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meningococcal Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meningococcal Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningococcal Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Meningococcal Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Meningococcal Vaccine Market Segments
Table 2. Ranking of Global Top Meningococcal Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meningococcal Vaccine Market Size Growth Rate by Type 2020-2026 (K Dose) & (US$ Million)
Table 4. Major Manufacturers of Quadrivalent
Table 5. Major Manufacturers of Bivalent
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Meningococcal Vaccine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Meningococcal Vaccine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact
Table 12. Global Meningococcal Vaccine Market Size Growth Rate by Application 2020-2026 (K Dose)
Table 13. Global Meningococcal Vaccine Market Size by Region (K Dose) & (US$ Million): 2020 VS 2026
Table 14. Global Meningococcal Vaccine Sales by Regions 2015-2020 (K Dose)
Table 15. Global Meningococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 16. Global Meningococcal Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Meningococcal Vaccine Sales by Manufacturers (2015-2020) (K Dose)
Table 18. Global Meningococcal Vaccine Sales Share by Manufacturers (2015-2020)
Table 19. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2019)
Table 21. Meningococcal Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Meningococcal Vaccine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Meningococcal Vaccine Price (2015-2020) (USD/Dose)
Table 24. Meningococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Meningococcal Vaccine Product Type
Table 26. Date of International Manufacturers Enter into Meningococcal Vaccine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 29. Global Meningococcal Vaccine Sales Share by Type (2015-2020)
Table 30. Global Meningococcal Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Meningococcal Vaccine Revenue Share by Type (2015-2020)
Table 32. Meningococcal Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 33. Global Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 34. Global Meningococcal Vaccine Sales Share by Application (2015-2020)
Table 35. North America Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 36. North America Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 37. North America Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 39. North America Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 40. North America Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 41. North America Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 42. North America Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 43. Europe Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 44. Europe Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 45. Europe Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 47. Europe Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 48. Europe Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 50. Europe Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Meningococcal Vaccine Sales by Region (2015-2020) (K Dose)
Table 52. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Meningococcal Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 56. Asia Pacific Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 58. Asia Pacific Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 59. Latin America Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 60. Latin America Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 64. Latin America Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 65. Latin America Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 66. Latin America Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 68. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 72. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 74. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. CSL Corporation Information
Table 91. CSL Description and Major Businesses
Table 92. CSL Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. CSL Product
Table 94. CSL Recent Development
Table 95. Baxter Corporation Information
Table 96. Baxter Description and Major Businesses
Table 97. Baxter Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Baxter Product
Table 99. Baxter Recent Development
Table 100. JN International Medical Corporation Corporation Information
Table 101. JN International Medical Corporation Description and Major Businesses
Table 102. JN International Medical Corporation Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. JN International Medical Corporation Product
Table 104. JN International Medical Corporation Recent Development
Table 105. Serum Institute of India Corporation Information
Table 106. Serum Institute of India Description and Major Businesses
Table 107. Serum Institute of India Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Serum Institute of India Product
Table 109. Serum Institute of India Recent Development
Table 110. Bio-Med Corporation Information
Table 111. Bio-Med Description and Major Businesses
Table 112. Bio-Med Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Bio-Med Product
Table 114. Bio-Med Recent Development
Table 115. China National Biotec Group Corporation Information
Table 116. China National Biotec Group Description and Major Businesses
Table 117. China National Biotec Group Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. China National Biotec Group Product
Table 119. China National Biotec Group Recent Development
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Major Businesses
Table 122. Hualan Bio Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Hualan Bio Product
Table 124. Hualan Bio Recent Development
Table 125. Walvax Corporation Information
Table 126. Walvax Description and Major Businesses
Table 127. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Walvax Product
Table 129. Walvax Recent Development
Table 130. Zhifei Corporation Information
Table 131. Zhifei Description and Major Businesses
Table 132. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Zhifei Product
Table 134. Zhifei Recent Development
Table 135. Global Meningococcal Vaccine Sales Forecast by Regions (2021-2026) (K Dose)
Table 136. Global Meningococcal Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Meningococcal Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Meningococcal Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 140. North America: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 142. Europe: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Meningococcal Vaccine Sales Forecast by Region (2021-2026) (K Dose)
Table 144. Asia Pacific: Meningococcal Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 146. Latin America: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 148. Middle East and Africa: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Meningococcal Vaccine Players
Table 153. Meningococcal Vaccine Customers List
Table 154. Meningococcal Vaccine Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. Meningococcal Vaccine Market Segments
Table 2. Ranking of Global Top Meningococcal Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meningococcal Vaccine Market Size Growth Rate by Type 2020-2026 (K Dose) & (US$ Million)
Table 4. Major Manufacturers of Quadrivalent
Table 5. Major Manufacturers of Bivalent
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Meningococcal Vaccine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Meningococcal Vaccine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Meningococcal Vaccine Players to Combat Covid-19 Impact
Table 12. Global Meningococcal Vaccine Market Size Growth Rate by Application 2020-2026 (K Dose)
Table 13. Global Meningococcal Vaccine Market Size by Region (K Dose) & (US$ Million): 2020 VS 2026
Table 14. Global Meningococcal Vaccine Sales by Regions 2015-2020 (K Dose)
Table 15. Global Meningococcal Vaccine Sales Market Share by Regions (2015-2020)
Table 16. Global Meningococcal Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Meningococcal Vaccine Sales by Manufacturers (2015-2020) (K Dose)
Table 18. Global Meningococcal Vaccine Sales Share by Manufacturers (2015-2020)
Table 19. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2019)
Table 21. Meningococcal Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Meningococcal Vaccine Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Meningococcal Vaccine Price (2015-2020) (USD/Dose)
Table 24. Meningococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Meningococcal Vaccine Product Type
Table 26. Date of International Manufacturers Enter into Meningococcal Vaccine Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 29. Global Meningococcal Vaccine Sales Share by Type (2015-2020)
Table 30. Global Meningococcal Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Meningococcal Vaccine Revenue Share by Type (2015-2020)
Table 32. Meningococcal Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 33. Global Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 34. Global Meningococcal Vaccine Sales Share by Application (2015-2020)
Table 35. North America Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 36. North America Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 37. North America Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 39. North America Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 40. North America Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 41. North America Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 42. North America Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 43. Europe Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 44. Europe Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 45. Europe Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 47. Europe Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 48. Europe Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 50. Europe Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Meningococcal Vaccine Sales by Region (2015-2020) (K Dose)
Table 52. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Meningococcal Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 56. Asia Pacific Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 58. Asia Pacific Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 59. Latin America Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 60. Latin America Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 63. Latin America Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 64. Latin America Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 65. Latin America Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 66. Latin America Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Meningococcal Vaccine Sales by Country (2015-2020) (K Dose)
Table 68. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Meningococcal Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Meningococcal Vaccine Sales by Type (2015-2020) (K Dose)
Table 72. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Meningococcal Vaccine Sales by Application (2015-2020) (K Dose)
Table 74. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. CSL Corporation Information
Table 91. CSL Description and Major Businesses
Table 92. CSL Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. CSL Product
Table 94. CSL Recent Development
Table 95. Baxter Corporation Information
Table 96. Baxter Description and Major Businesses
Table 97. Baxter Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Baxter Product
Table 99. Baxter Recent Development
Table 100. JN International Medical Corporation Corporation Information
Table 101. JN International Medical Corporation Description and Major Businesses
Table 102. JN International Medical Corporation Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. JN International Medical Corporation Product
Table 104. JN International Medical Corporation Recent Development
Table 105. Serum Institute of India Corporation Information
Table 106. Serum Institute of India Description and Major Businesses
Table 107. Serum Institute of India Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Serum Institute of India Product
Table 109. Serum Institute of India Recent Development
Table 110. Bio-Med Corporation Information
Table 111. Bio-Med Description and Major Businesses
Table 112. Bio-Med Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Bio-Med Product
Table 114. Bio-Med Recent Development
Table 115. China National Biotec Group Corporation Information
Table 116. China National Biotec Group Description and Major Businesses
Table 117. China National Biotec Group Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. China National Biotec Group Product
Table 119. China National Biotec Group Recent Development
Table 120. Hualan Bio Corporation Information
Table 121. Hualan Bio Description and Major Businesses
Table 122. Hualan Bio Meningococcal Vaccine Production (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Hualan Bio Product
Table 124. Hualan Bio Recent Development
Table 125. Walvax Corporation Information
Table 126. Walvax Description and Major Businesses
Table 127. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Walvax Product
Table 129. Walvax Recent Development
Table 130. Zhifei Corporation Information
Table 131. Zhifei Description and Major Businesses
Table 132. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Zhifei Product
Table 134. Zhifei Recent Development
Table 135. Global Meningococcal Vaccine Sales Forecast by Regions (2021-2026) (K Dose)
Table 136. Global Meningococcal Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Meningococcal Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Meningococcal Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 140. North America: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 142. Europe: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Meningococcal Vaccine Sales Forecast by Region (2021-2026) (K Dose)
Table 144. Asia Pacific: Meningococcal Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 146. Latin America: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Meningococcal Vaccine Sales Forecast by Country (2021-2026) (K Dose)
Table 148. Middle East and Africa: Meningococcal Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Meningococcal Vaccine Players
Table 153. Meningococcal Vaccine Customers List
Table 154. Meningococcal Vaccine Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Meningococcal Vaccine Product Picture
Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Quadrivalent Product Picture
Figure 4. Bivalent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others (Arthritis, Conjunctivitis, Urethritis)
Figure 11. Meningococcal Vaccine Report Years Considered
Figure 12. Global Meningococcal Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global Meningococcal Vaccine Sales 2015-2026 (K Dose)
Figure 14. Global Meningococcal Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Meningococcal Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Meningococcal Vaccine Sales Market Share by Region in 2019
Figure 17. Global Meningococcal Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Meningococcal Vaccine Revenue Market Share by Region in 2019
Figure 19. Global Meningococcal Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Meningococcal Vaccine Revenue in 2019
Figure 21. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 24. Global Meningococcal Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global Meningococcal Vaccine Revenue Market Share by Type in 2019
Figure 26. Global Meningococcal Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 29. Global Meningococcal Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global Meningococcal Vaccine Revenue Market Share by Application in 2019
Figure 31. North America Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 32. North America Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 34. North America Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 35. U.S. Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 36. U.S. Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 38. Canada Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Meningococcal Vaccine Market Share by Type in 2019
Figure 40. North America Meningococcal Vaccine Market Share by Application in 2019
Figure 41. Europe Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 42. Europe Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 44. Europe Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 45. Germany Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 46. Germany Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 48. France Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 50. U.K. Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 52. Italy Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 54. Russia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Meningococcal Vaccine Market Share by Type in 2019
Figure 56. Europe Meningococcal Vaccine Market Share by Application in 2019
Figure 57. Asia Pacific Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 58. Asia Pacific Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region in 2019
Figure 61. China Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 62. China Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 64. Japan Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 66. South Korea Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 68. India Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 70. Australia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 72. Taiwan Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 74. Indonesia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 76. Thailand Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 78. Malaysia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 80. Philippines Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 82. Vietnam Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Meningococcal Vaccine Market Share by Type in 2019
Figure 84. Asia Pacific Meningococcal Vaccine Market Share by Application in 2019
Figure 85. Latin America Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 86. Latin America Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 90. Mexico Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 92. Brazil Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 94. Argentina Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Meningococcal Vaccine Market Share by Type in 2019
Figure 96. Latin America Meningococcal Vaccine Market Share by Application in 2019
Figure 97. Middle East and Africa Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 98. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 101. Turkey Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 102. Turkey Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 104. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 106. UAE Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Meningococcal Vaccine Market Share by Type in 2019
Figure 108. Middle East and Africa Meningococcal Vaccine Market Share by Application in 2019
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. JN International Medical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Walvax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 122. North America Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 124. Europe Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 126. Asia Pacific Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 128. Latin America Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 130. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Meningococcal Vaccine Product Picture
Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Quadrivalent Product Picture
Figure 4. Bivalent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others (Arthritis, Conjunctivitis, Urethritis)
Figure 11. Meningococcal Vaccine Report Years Considered
Figure 12. Global Meningococcal Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global Meningococcal Vaccine Sales 2015-2026 (K Dose)
Figure 14. Global Meningococcal Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Meningococcal Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Meningococcal Vaccine Sales Market Share by Region in 2019
Figure 17. Global Meningococcal Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Meningococcal Vaccine Revenue Market Share by Region in 2019
Figure 19. Global Meningococcal Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Meningococcal Vaccine Revenue in 2019
Figure 21. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Meningococcal Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global Meningococcal Vaccine Sales Market Share by Type in 2019
Figure 24. Global Meningococcal Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global Meningococcal Vaccine Revenue Market Share by Type in 2019
Figure 26. Global Meningococcal Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global Meningococcal Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global Meningococcal Vaccine Sales Market Share by Application in 2019
Figure 29. Global Meningococcal Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global Meningococcal Vaccine Revenue Market Share by Application in 2019
Figure 31. North America Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 32. North America Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 34. North America Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 35. U.S. Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 36. U.S. Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 38. Canada Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Meningococcal Vaccine Market Share by Type in 2019
Figure 40. North America Meningococcal Vaccine Market Share by Application in 2019
Figure 41. Europe Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 42. Europe Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 44. Europe Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 45. Germany Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 46. Germany Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 48. France Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 50. U.K. Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 52. Italy Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 54. Russia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Meningococcal Vaccine Market Share by Type in 2019
Figure 56. Europe Meningococcal Vaccine Market Share by Application in 2019
Figure 57. Asia Pacific Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 58. Asia Pacific Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region in 2019
Figure 61. China Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 62. China Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 64. Japan Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 66. South Korea Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 68. India Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 70. Australia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 72. Taiwan Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 74. Indonesia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 76. Thailand Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 78. Malaysia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 80. Philippines Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 82. Vietnam Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Meningococcal Vaccine Market Share by Type in 2019
Figure 84. Asia Pacific Meningococcal Vaccine Market Share by Application in 2019
Figure 85. Latin America Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 86. Latin America Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 88. Latin America Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 89. Mexico Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 90. Mexico Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 92. Brazil Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 94. Argentina Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Meningococcal Vaccine Market Share by Type in 2019
Figure 96. Latin America Meningococcal Vaccine Market Share by Application in 2019
Figure 97. Middle East and Africa Meningococcal Vaccine Sales Growth Rate 2015-2020 (K Dose)
Figure 98. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country in 2019
Figure 101. Turkey Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 102. Turkey Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 104. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Meningococcal Vaccine Sales Growth Rate (2015-2020) (K Dose)
Figure 106. UAE Meningococcal Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Meningococcal Vaccine Market Share by Type in 2019
Figure 108. Middle East and Africa Meningococcal Vaccine Market Share by Application in 2019
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. JN International Medical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Walvax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 122. North America Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 124. Europe Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 126. Asia Pacific Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 128. Latin America Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Meningococcal Vaccine Sales Growth Rate Forecast (2021-2026) (K Dose)
Figure 130. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
